Bank Pictet & Cie Europe AG Has $133.37 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bank Pictet & Cie Europe AG boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 263,655 shares of the healthcare conglomerate’s stock after purchasing an additional 9,872 shares during the period. UnitedHealth Group makes up about 2.9% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 6th largest holding. Bank Pictet & Cie Europe AG’s holdings in UnitedHealth Group were worth $133,373,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. AMF Tjanstepension AB lifted its position in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after acquiring an additional 121,180 shares during the last quarter. Hudson Value Partners LLC lifted its position in shares of UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the last quarter. Wealth Group Ltd. lifted its position in shares of UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after acquiring an additional 68 shares during the last quarter. Creative Planning lifted its position in shares of UnitedHealth Group by 11.0% during the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock valued at $123,025,000 after acquiring an additional 21,114 shares during the last quarter. Finally, Good Life Advisors LLC lifted its position in shares of UnitedHealth Group by 50.6% during the 3rd quarter. Good Life Advisors LLC now owns 1,545 shares of the healthcare conglomerate’s stock valued at $903,000 after acquiring an additional 519 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

NYSE UNH opened at $523.48 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock’s 50-day moving average is $523.63 and its two-hundred day moving average is $563.48. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $481.75 billion, a P/E ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the previous year, the company posted $5.83 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.